Aviptadi CAS:40077-57-4
Aviptadil, derived from vasoactive intestinal polypeptide (VIP), is utilized in various therapeutic applications, primarily in the treatment of pulmonary hypertension and erectile dysfunction. In the treatment of pulmonary hypertension, aviptadil acts as a pulmonary vasodilator, meaning it dilates blood vessels specifically in the lungs. This effect helps to reduce pulmonary vascular resistance, easing the workload on the heart and improving blood flow to the lungs. Aviptadil's vasodilatory properties are beneficial in conditions where pulmonary hypertension causes increased pressure in the arteries of the lungs, leading to symptoms such as shortness of breath and fatigue. Aviptadil is also employed in the management of erectile dysfunction (ED). It works by enhancing blood flow to the penis, which is crucial for achieving and maintaining an erection. As a vasodilator, aviptadil relaxes the smooth muscles of the blood vessels in the penis, allowing for increased blood flow during sexual arousal. This mechanism of action makes aviptadil a valuable treatment option for individuals experiencing difficulties with erectile function. The administration of aviptadil varies depending on the condition being treated. In pulmonary hypertension, it may be delivered via inhalation or intravenous infusion to target the lungs directly and achieve rapid vasodilation. For erectile dysfunction, aviptadil may be administered intracavernosally (directly into the penis) to facilitate local vasodilation and improve erectile function. Clinical studies have demonstrated the efficacy and safety of aviptadil in improving symptoms and quality of life in patients with pulmonary hypertension and erectile dysfunction. Its targeted vasodilatory effects make it a valuable therapeutic option, particularly for individuals who may not respond adequately to other treatments or who prefer a non-oral route of administration. In conclusion, aviptadil represents a significant advancement in the treatment of pulmonary hypertension and erectile dysfunction, addressing critical aspects of these conditions by improving pulmonary vascular function and enhancing erectile response. Its versatility and efficacy underscore its role as a promising therapeutic agent in improving cardiovascular and sexual health outcomes for patients worldwide.
Composition | C147H238N44O42S |
Assay | 99% |
Appearance | white powder |
CAS No. | 40077-57-4 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |